The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
Columvi is part of Roche's industry-leading portfolio of T-cell engaging bispecific antibodies in non-Hodgkin lymphoma, which also includes the recently approved Lunsumio to treat follicular lymphoma
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
Thiamine Hydrochloride Injection USP had estimated annual sales of USD 35 million in the U.S.
Convergent action on AMR identified as an important area of intervention
The inspection closed with zero observations
Subscribe To Our Newsletter & Stay Updated
